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P¼0.044), percentage of neutrophils (r¼-0.355, P<0.001), NLR (r¼-0.429, P<0.001)
were negatively correlated with LVEF value.
Conclusions: (1) STR 50% and long time of chest pain to balloon are independent
risk factors of perioperative heart failure in patients with acute STEMI undergoing
emergency PCI. (2) Using of tiroﬁban has good protective effect on perioperative
cardiac function in patients with acute STEMI undergoing emergency PCI. (3) The
increased NLR is a risk factor of perioperative heart failure in patients with acute
STEMI undergoing emergency PCI. And NLR has good correlation with perioperative
left ventricular ejection fraction.
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The feasibility study on the biventricular pacing both dynamic combined of
atrioventricular nodal conduction to improve the treatment of heart failure
Qin Zuoan, Li Ruijie, Guo Tao
First Afﬁliated Hospital of Kunming Medical College
Objectives: Assess the biventricular pacing dynamic combined of atrioventricular
nodal conduction function and improve the efﬁcacy of the cardiac pacing.
Methods: From 2012 January to 2013 September, we have selected the 30 patients
who are admitted to the First Afﬁliated Hospital of Kunming Medical University and
accorded with the CRT IA indication of the 2013 ACCF/AHA/HRS guidelines. 30
patients were randomly divided into dynamic group and non-dynamic control group,
with 15 cases in each group. all patients completed immediately, 3 month and 6 month
followed of take the ECG, 24 h Holter, echocardiography, NYHA, 6 MWT, MLHF
and so on. We analyze data by using SPSS 17 statistical software package, P<0.05.
Results: (1) The two group immediate width of QRS after optimized was more
narrow than the traditional AVd optimization method, in the dynamic group
(138.3321.83 ms and 169.13 20.31 ms, P<0.001); in the control group
(133.3313.58 ms and 174.3315.69 ms, P<0.001). (2) Compared the ﬁrst opti-
mized immediately, both Ts-SD12 and AVTI values improved in after 6 months. In
the dynamic balance group (Ts-SD12 117.2042.78 ms and 147.4037.70 ms;
AVTI 20.494.30 cm and 18.252.14 cm, P<0.05); In the control group (Ts-
SD12 116.8036.26 ms and 154.2729.71 ms; AVTI 19.092.05 cm and
17.362.53 cm, P<0.05).The comparison of 6 months follow-up measurement
value, difference in two group had no signiﬁcant (117.2042.78 ms and
116.8036.26 ms, P¼0.937; 20.494.30 cm and 19.092.05 cm, P¼0.245). (3)
CRT preoperatively, after immediately optimized, with 3 months, 6 months follow-
up detection of ultrasonic index comparison, the difference of inter-group improved
(P<0.05), but the difference between the groups had no signiﬁcant (P>0.05). (4)
Compared with the ﬁrst optimized immediately, NYNA / 6WMT / MLHF of all
patients with 6 months in two groups were improved.NYNA (the dynamic group
1.60.5 and the control group 2.70.6;1.50.5 and 2.60.6, P<0.05); 6MWT
(the dynamic group 379.6728.75 m and 337 25.13 m; the control group
38130.66 m and 346.4731.98 m, P<0.001); MLHF (the dynamic group 28
10.73 and 36.87 16.44; the control group 25.3315.61 and 36.6720.91,
P<0.05).The difference of the indexes between the two groups with follow-up of
6 months was no signiﬁcant (NYNA1.60.5 and 1.50.5; 6MWT 379.6728.75 m
and 38130.66 m; MLHF 28.0010.73 and 25.3315.61, P>0.05). (5) Compared
with the ﬁrst optimization after 24 h ECG, dynamic group with the best “true fusion
QRS wave” is higher than the control group (80.67% and 52.67%, P¼0.001);
“ventricular false convergence” between the two groups accounted for the proportion
of total cardiac was lower than 2%, and there was no signiﬁcant (1.28% and 1.74%,
P¼0.427).
Conclusions: (1) With sinus rhythm in patients with CHF were treated by CRT and
both the “atrioventricular node priority” and allowed 100% “true fusion” and “false
fusion” biventricular pacing capture classic mode. This type lead to narrower QRS
wave. (2) Biventricular pacing both atrioventricular nodal intrinsic conduction is
simple, noninvasive safety, The patients implanted CRT with narrower QRS wave can
improve heart function and quality of life and the response rate. There is an increasing
trend to beneﬁt to the patients with implementation of biventricular pacing “atrio-
ventricular node priority”. (3) Dynamic balance of atrioventricular node intrinsic
conduction “3 Chamber&4 site Pacing” mode, improve biventricular pacing stimulus
and AV node conduction “really inherent fusion QRS wave”.
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Study on the Effect of Luo Feng Ning NO.2 to the Quality of Life of patients with
Cardiorenal Syndrome
Wang Xian1,2, Yang Xue-Qing1,2, Li Xue-Feng1, Zhu Hai-Yan1
1Dongzhimen hospital Afﬁliated to Beijing University of Chinese Medicine, 2Beijing
University of Chinese Medicine
Objectives: To investigate the effect of Luo Feng Ning NO.2 to the quality of life of
patients with cardiorenal syndrome.
Methods: 46 patients with cardiorenal syndrome patients were randomly divided into
the Luo Feng Ning NO.2 group (n¼12), the expelling wind drug group (n¼10), the
remove expelling wind drug group (n¼9), and the western medicine group (n¼15).
Minnesota Living With Heart Failure Questionnaire, 6-minute walk test, the standard
of curative effect evaluation, and the typical symptom quantitative score of heart and
kidney were used as the, index for appraising quality of life before and after 3 months
treatment, respectively.
Results: After 3 months treatment, MLHFQ score of the Luo Feng Ning NO.2 group,
the expelling wind drug group, the remove expelling wind drug group was statisticallyJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Csigniﬁcant (P<0.05) compared with before treatment, while MLHFQ score of the
western medicine group tends to aggravate. Comparison among groups, the score of
the Luo Feng Ning NO.2 group was the lowest by the obvious improvement and the
difference was statistically signiﬁcant (P<0.05). Comparison before and after
3 months treatment among in the four groups, 6-minute walking distance were all
prolonged, the difference was statistically signiﬁcant (P<0.05). But the differences
were not statistically signiﬁcant (P>0.05) among the four groups. After the treatment,
the total efﬁciency of four groups from large to small order: the Luo Feng Ning NO.2
group, the expelling wind drug group, the remove expelling wind drug group, western
medicine group. After 3 months, the typical symptom score of four groups have no
statistically signiﬁcance (P>0.05).That is not obvious symptoms improvement before
and after treatment. But from the view of x s, the typical symptom quantitative score
of the Luo Feng Ning NO.2group, wind drug group, remove wind drug group all have
increased and the Luo Feng Ning NO.2 group was obviously lower, while the western
medicine group score changed little or increased.
Conclusions: Luo Feng Ning NO.2 can improve the quality of life on cardiorenal
syndrome patients.
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Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary
hypertension secondary to chronic systolic heart failure
Wu Xiaojing, Huang Lan
Cardiovascular Department of Xinqiao Hospital, Third Military Medical University
Objectives: Increased indiscriminate use of pulmonary artery hypertension targeted
drugs has been observed in patients with pulmonary hypertension (PH) secondary to
heart failure. We performed a meta-analysis to evaluate the chronic effects of using
phosphodiesterase 5 (PDE5) inhibitors to treat patients with PH secondary to chronic
systolic heart failure.
Methods: PubMed, EMBASE, and the Cochrane Library were searched through
October 2013 for randomized controlled trials (RCTs) assessing PDE5 inhibitor
treatments in PH patients secondary to chronic heart failure. Six RCTs involving 206
chronic systolic heart failure patients with PH complications were included.
Results: Sildenaﬁl was used in all trials. Sildenaﬁl treatment resulted in fewer hospital
admissions compared with the placebo treatment (3.15% versus 12.20%; risk ratio,
0.29; 95% conﬁdence interval, 0.11-0.77). Various hemodynamic parameters were
improved with additional sildenaﬁl treatment, including reduced mean pulmonary
artery pressure (weighted mean differences, [WMD], -5.71 mmHg, P<0.05), and
pulmonary vascular resistance (WMD, -81.5 dynes/cm-5, P<0.00001), increased left
ventricular ejection fraction (WMD, 3.95%, P<0.001), and unchanged heart rate and
blood pressure. The exercise capacity improved (Oxygen consumption at peak exer-
cise, WMD, 3.20 ml/min-1/kg-1, P<0.00001; Ventilation to CO2 production slope,
WMD, -5.89, P<0.00001), and the clinical symptoms were relieved based on the
breathlessness (WMD, 7.72, P<0.00001), fatigue (WMD, 2.28, P<0.05), and
emotional functioning (WMD, 5.92, P<0.00001) scores.
Conclusions: Additional sildenaﬁl treatment is a potential therapeutic method to
improve pulmonary exercise capacity and quality of life by ameliorating PH in
patients with chronic systolic heart failure.
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Research on Diagnostic Criteria of Congestive Heart Failure with Qi-yin
Deﬁciency Syndrome and Yang-deﬁciency-water-overﬂowing Syndrome Based
on Clinical epidemiological Survey
Li Xiaoqian, Hejiancheng, Cao Xuebing, He Jiancheng
Shanghai University of T.C.M
Objectives: To discuss the clinical rules of TCM four diagnostic information and
relevant indicators in qi-yin-deﬁciency syndrome and yang-deﬁciency-water-
overﬂowing syndrome of congestive heart failure, and consummate diagnosis criteria
of the two syndromes.
Methods: 750 CHF cases from multicenter (from Dec, 2012 to Dec, 2013) were
collected by applying TCM syndrome scale of congestive heart failure. Related items,
primary and secondary symptoms of syndromes were screened by the method of
logistic regression. The assignment of items related to the syndromes was by means of
conditional probability conversion method. The threshold values in clinic diagnosis of
qi-yin-deﬁciency syndrome and yang-deﬁcieny-water-overﬂowing syndrome got
determined combined with ROC curve. Reference range of BNP also got described by
the mean value and median.
Results: Based on retrospective analysis of clinical cases (1694 cases), applying rank
sum test, Spearman rank correlation analysis, clustering and factor analysis, results
indicated: qi-yin-deﬁciency syndrome is one of the common patterns of CHF, and
yang-deﬁciency-water-overﬂowing syndrome can be mostly seen in the later period.
The major deﬁning characteristics of qi-yin-deﬁciency with blood-stasis syndrome are
thirst, cyanotic lips, sweating, frequent nigh urination, teeth-printed or cyanotic
tongue, uneven or irregular pulse. The minor characteristics are loose stool, headache,
and bulgy tongue with slip or little fur, slow, weak, or ﬂoating pulse. The major
characteristic of yang-deﬁciency-water-overﬂowing syndrome are cough, expectora-
tion, insomnia, bad appetite, difﬁcult urination, edema of lower limbs, greasy fur and
string pulse. The minor one is fatigue. The diagnosis criteria of CHF qi-yin-deﬁciency
syndrome is total score of related items is equal or greater than 68 points (sensitivity:
95%, speciﬁcity: 82.4%), and the reference range of BNP is from 93.57 to 182.59
pg/ml. The diagnosis criteria of yang-deﬁciency-water-overﬂowing syndrome is totalardiovascular Disease Clinical Research C185
score is equal or greater than 62 points (sensitivity: 89.6%, speciﬁcity: 83.8%), and
BNP is from 509.86 to 1091.42 pg/ml. Besides, the results of retrospective and
prospective clinical assess showed all of the sensitivity, speciﬁcity and accuracy
degree were above 90%, and positive likelihood ratios were almost greater than 10.
Conclusions: The clinical diagnosis criteria of qi-yin-deﬁciency syndrome and yang-
deﬁciency-water-overﬂowing syndrome divide symptoms and signs into major and
minor deﬁning characteristics, by considering the variation of BNP. It has higher
sensitivity, speciﬁcity and accuracy, which can be better applied in clinical practice.
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A prospective, single-blind, randomized, controlled and multicenter clinical trial
of standardized Western therapy alone or combined with traditional Chinese
medication staging-differentiation treatment in patients with chronic heart
failure: Results of the SECETCM-HF
Xianliang Wang, Jingyuan Mao
Cardiovascular Department of the First Teaching Hospital of Tianjin University of
Traditional Chinese Medicine
Objectives: To compare the efﬁcacy of standardized western therapy alone and
combined with traditional Chinese medication staging-differentiation treatment in
patients with chronic heart failure (CHF).
Methods: In total, 340 CHF patients aged 40-79 years were randomized into control or
treatment groups on admission. The trial included three periods of intervention and
comprehensive evaluation. During the hospitalization, the control group received stan-
dard medication plus a polarized solution. Patients in the treatment group also received a
Shenfu injection for qi-yang deﬁciency or a Shenmai injection for qi-yin deﬁciency along
with a Danhong injection. After the discharge, all patients were continually treated with
standardized medication plus the study drugs (Qiliqiangxin capsule for qi-yang deﬁ-
ciency and Buyiqiangxin tablets for qi-yin deﬁciency) or a placebo for 6 months. After
6 month visits, both groups received the standard medication alone.
Results: On discharge, the treatment group showed greater improvement in the six-
minute walk test (6MWT; P<0.05) compared with the control group. After 12 months
of follow-up, there was a time-group interaction for Minnesota Living with Heart
Failure Questionnaire (MLHFQ) (P¼0.03). The K-M curves for the cumulative sur-
vival rate showed no signiﬁcant difference between the two groups (P¼0.208), but the
treatment group tended to have better survival. The adverse events and safety proﬁle
of the interventions were similar in the two groups (P>0.05).
Conclusions: Standardized medication plus TCM staging-differentiation treatment
improves cardiopulmonary function and quality of life and have tend to increases the
survival rate.
GW25-e2181
The effect of different altitude hypoxia on hemin oxygenase (HO) -1/CO-bilirubin
system in elderly patients with congestive heart failure
Xi Aiqi, Zhong Xin, Liao Bao-Xia, Li Guo-Feng, Tang Xiaolan
Geriatrics Department, The People’s Hospital of Qinghai Province, Xining, Qinghai
Objectives: High altitude (HA) presents inhospitable environmental conditions that
adversely affects human physiology and metabolism. Changes in physiological
functions are reported during high altitude exposure. yet, Few study have explored the
effect of different altitude hypoxia (2260 m, 3300-3500 m) on hemin oxygenase (HO)
-1/CO-bilirubin system in elderly patients (65 years old) with congestive heart
failure, and to evaluate the relationship with left ventricular mass index (LVMI), mean
wall stress (MWS) and cardiac function.
Methods: CHF patients (n¼56) from high altitude were studied and 69 CHFs from
moderate altitude (2260 m) were enrolled as controls, the serum levels of heme oxy-
genase-1 (HO-1), carbox yhemoglobin (COHb) were detected. Their Left ventricular
ejection fraction (LVEF) LVMI and MWS were measured by echocardiography.
Results: Compared with moderate altitude group, the serum levels of HO-1 and
COHb were obviously increased in high altitude group[HO-1 (127.812.8) vs
(86.58.4) nmol/h.L; COHb (9.431.36) % vs (5.270.75) %respectively]. Simi-
larly, LVMI and MWS were signiﬁcantly higher in high altitude group [(182.38.7)
vs (98.45.3) g/m2 and (453.815.7) vs (299.410.1) dynes x103/cm2, respectively].
there was a positive correlation between LVMI, MWS and the levels of HO-1, COHb
(all P<0.01).
Conclusions: With the increase of altitude, CHF patients had higher levels of HO-1,
COHb. the unbalance of oxidation/ antioxidation pay important roles in pathophysio-
logical and pathogeneticmechanism of ventricular remodeling in CHF from high altitude.
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To evaluate the effect of PCI in the patients who get the anterior myocardial
infarction with ventricular aneurysm and the change of N-terminal B-type
natriuretic peptide (BNP), serum high-sensitivity C-reactive protein (hs-CRP),
and analysis of the aneurysm patients in perioperative period of PCI TCM
syndrome type changes that can be used
Wang Xianghe, Zhang Ting, Cao Xuebin
The 252nd Hospital of PLA
Objectives: To evaluate the effect of PCI in the patients who get the anterior
myocardial infarction with ventricular aneurysm and the change of N-terminal B-typeC186 JACC Vol 64/16/Suppl C j October 16–1natriuretic peptide (BNP), serum high-sensitivity C-reactive protein (hs-CRP) in
perioperative period of PCI, and whether these factors could be early predictors of
ventricular aneurysm. Finally analysis of the aneurysm patients in perioperative period
of PCI TCM syndrome type changes that can be used, conditioning, the Integrative
inhibition of ventricular remodeling.
Methods: 43 cases with anterior myocardial infarction who underwent PCI, including
31 males and 12 females, average aged 58.312.1 (55-69) years old; previous PCI,
severe infection, tumors, rheumatic diseases, infectious disease, liver and renal
insufﬁciency excluded. Based on left ventricular angiography, the patients were
divided into ventricular aneurysm group and control group. All patients were got the
blood serum sample of hs-CRP, BNP before PCI, and hs-CRP 12-16 h or serum BNP
after 48 h. Ultrasonic cardiogram, ECG, serum proBNP and hs-CRP were followed up
in one month. First of all, according to EF and left ventricular internal diameter of
1 month after surgery in the ventricular aneurysm group, 25 people conﬁrmed the
signiﬁcance of the PCI in ventricular aneurysm in patients. Followed by between
ventricular aneurysm groups and control groups compare hs-CRP preoperative and
postoperative 12-16 h, BNP preoperative postoperative 48 h and after one month,
making a comparison conﬁrmed that hs-CRP and BNP for ventricular aneurysm in
patients undergoing PCI of the predictive value.
Results: (1) Compared pre-PCI and 48 h after PCI in Ventricular aneurysm group, the
LVEF (Left ventricular eject fraction, LVEF; 0.5470.101 vs 0.5650.092,
P¼0.513>0.05) and LVEDD (left ventricular diastolic diameter, LVEDD;
52.526.838 vs 50.845.720, P¼0.351 >0.05) were not signiﬁcant difference. But
there were signiﬁcant difference of LVEF (0.5470.101 vs 0.6020.072, P¼0.031
<0.05) and LVEDD (52.526.838 vs 47.164.119, P¼0.002 <0.05) between pre-
PCI and one month after PCI. (2) Compared to Control group, serum hs-CRP pre-
operative, postoperative 12-16h in the ventricular aneurysm group were signiﬁcant
increase (3.50 (1.37-12.38) vs 0.98 (0.27-5.10), 3.12 (1.85-9.41) vs 1.11 (0.21-3.33),
P value were 0.012 and 0.01). Serum NT-proBNP pre-PCI, 48 h and a month after PCI
in the ventricular aneurysm group were signiﬁcant difference (1173.00 (518.75-
198.50) vs 439.30 (123.33-912.83), 1008.00 (625.70-1914.50) vs 331.05 (138.75-
781.08), 658.00 (498.00-1184.00) vs 349.00 (114.25-534.00), P value ¼0.013, 0.01,
0.003). (3) Preoperative TCM, more than 43 cases of patients with anterior myocardial
infarction and blood deﬁciency, blood stasis - based PCI postoperative Qi Deﬁciency,
blood stasis, heart yang lack of permit, Qi blood stasis and heat toxin attacks the card,
liver and spleen do not tune the card.
Conclusions: (1) PCI can improve heart function to anterior myocardial infarction
with Left ventricular aneurysm patients. (2) Serum hs-CRP and NT-proBNP maybe
predictive value for anterior myocardial infarction with Left ventricular aneurysm
patients. (3) 43 cases of patients before surgery, TCM Integrative conditioning the
patients, which will help patients with early rehabilitation.
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Xinshuitong Capsule via aquaporin-2 enhances Xinshuitong Capsule via
aquaporin-2 enhances the diuretic effect in the chronic heart failure patients
Tan Chunjiang1, Xiao Lu1, Chen Songming2
1Fujian University of Traditional Chinese Medicine, 2The First Afﬁliated Hospital of
Shantou University
Objectives: Aquaporin-2 (AQP-2), which was involved in renal water reabsorption,
was found high in the urine of chronic heart failure (CHF) patients. Xinshuitong
Capsule (XC) has natriuretic effect in CHF patients, however, whether this effect
related to AQP pathway remains unclear.
Methods: 36 NYHA IIand III CHF patients were randomized into three groups:
routine therapy (RT), routine therapy plus XC (RX) or plus placebo (RP), all the
patients received furosemide treatment (60 mg/d). Quality of life (QL) was assessed
by SF-36 Health Status Survey. Urine AQP-2, 24 h urine volume, free water clearance
(CH2O) and fractional excretion of sodium (FENa), plasma vasopressin (AVP), renin,
angiotensin II (Ang II), aldosterone (Aldo), atrial (ANP) and brain natriuretic peptides
(BNP) were measured before or every day in the 15-day study.
Results: The groups were matched for age, gender, race, baseline indexes, and NYHA
class stratiﬁcation. Compared to RT or RP group, urinary AQP-2 excretion decreased
in RX group from day 2, and the signiﬁcant decrease was observed at day 6 and
this level maintained until the end of the study (pmol / ml: day0, 9221; day 1,
7213; day 2, 5510; day 3, 4411; day 4, 3511; day 5, 227; day 6, 155; day 6
vs. day 0, P<0.05). CH2O lower in RX compared to RT or RP. Plasma levels of AVP
(20%), renin (12%), Ang II (9%) and Aldo (17%) were lower in RX compared to RT
and RP, however, plasma levels of ANP and BNP showed no difference among the
three groups. QL and NYHA class in RX improved in varying degrees compared with
the other two groups.
Conclusions: XC could increase urine output and inhibit water reabsorption via the
APQ2 water channel, and XC also had pharmacodynamic actions on AVP and the
renin-angiotensin-aldosterone system and synergistically enhanced natriuretic effects
in CHF patients.
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Congestive Heart Failure Based on Literature Analysis, Clinical Retrospective
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